Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sevgi Akarsu is active.

Publication


Featured researches published by Sevgi Akarsu.


Journal of The European Academy of Dermatology and Venereology | 2006

Evaluation of dermoscopic and histopathologic features and their correlations in pigmented basal cell carcinomas

M Demırtaşoǧlu; Turna Ilknur; Banu Lebe; E Kuşku; Sevgi Akarsu; Şebnem Özkan

Background  Because of their clinical similarities, pigmented basal cell carcinomas (BCCs) can be confused with melanocytic pigmented lesions especially with melanoma. Since special dermoscopic features have been described for pigmented BCCs, dermoscopy is accepted as a useful tool for the diagnosis of pigmented BCCs.


Clinical and Experimental Dermatology | 2011

Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses

Sevgi Akarsu; Şebnem Aktan; A. Atahan; P. Koç; Şebnem Özkan

Background.  There is a wide spectrum of treatments available for actinic keratosis (AK). Topical diclofenac sodium and imiquimod are two topical treatments, which are noninvasive, easily applied, well‐tolerated and effective.


Dermatologic Surgery | 2006

Comparison of the Effects of Pulsed Dye Laser, Pulsed Dye Laser+Salicylic Acid, and Clobetasole Propionate+Salicylic Acid on Psoriatic Plaques

Turna Ilknur; Sevgi Akarsu; Şlebnem Aktan; Şlbnem Özkan

BACKGROUND Studies show that pulsed dye laser (PDL) has some clinical benefits on psoriasis with a low clearance rate. In addition, it has been suggested that applying keratolytics before treatment might be helpful in PDL therapy. Topical corticosteroids remain the most commonly prescribed agents for psoriasis. OBJECTIVE This study was designed to compare the efficacy of the PDL treatment with that of PDL treatment after salicylic acid on psoriatic plaques. The other goal of this study was to compare the efficacy of the PDL treatment with that of clobetasol propionate treatment. METHODS Twenty-two patients with chronic, stable psoriatic plaques that involved less than 20% of their body were included in the study. Three similar-appearing psoriasis plaques in these patients were selected. Whereas the first plaque received only PDL, the second plaque received PDL after salicylic acid, and the third plaque received clobetasol propionate ointment and salicylic acid. Evaluation of the study plaques was carried out by the modified Psoriasis Area and Severity Index (mPASI) score and by measuring the area of the plaques. RESULTS Of the 21 patients, 19 completed the study. Although the decrease in mPASI scores was determined to be maximum for clobetasol propionate + salicylic acid-treated plaques and minimum for only PDL-treated plaques, the decrease was statistically significant in all groups when compared with baseline (p < .003). At the 3- and 6-week evaluations, there was a statistically significant difference between clobetasol propionate + salicylic acid-treated plaques and the two PDL-treated plaques (p < .003); however, the difference observed at the 9-, 12-, and 15-week evaluations was statistically significant only between clobetasol propionate + salicylic acid-treated plaques and PDL-treated plaques (p < .003). When the baseline and 15-week evaluations were compared, there was no statistically significant increase in the mean lesion areas of clobetasol propionate + salicylic acid-treated psoriatic plaques (p > .003), but there was a statistically significant increase in the mean lesion areas of two PDL-treated psoriatic plaques (p < .003). CONCLUSION The results of this study showed that the effect of PDL could be increased when salicylic acid was added to treatment, although there was no statistically significant difference between both treatment protocols. However, clobetasol propionate + salicylic acid treatment is more effective than both PDL and PDL + salicylic acid treatment.


Journal of The European Academy of Dermatology and Venereology | 2006

Verruca vulgaris : pulsed dye laser therapy compared with salicylic acid + pulsed dye laser therapy

Sevgi Akarsu; Turna Ilknur; M Demırtaşoǧlu; Şebnem Özkan

Background  In recent years, lasers have been used in verruca therapy and some successful results have been obtained in some types of verruca. In some of these laser studies, peeling processes have been used to increase penetration.


Journal of The European Academy of Dermatology and Venereology | 2011

Comparison of tretinoin 0.05% cream and 3% alcohol-based salicylic acid preparation in the treatment of acne vulgaris.

L Babayeva; Sevgi Akarsu; Emel Fetil; Ali Tahsin Güneş

Background No single effective topical treatment is available for treating all pathogenic factors causing acne vulgaris (AV). Salicylic acid (SA), tretinoin (all‐TRA) and clindamycin phosphate (CDP) are known to to be effective agents depending on their comedolytic and anti‐inflammatory properties.


Journal of Dermatology | 2006

Angioma serpiginosum: Dermoscopy for diagnosis, pulsed dye laser for treatment

Turna Ilknur; Emel Fetil; Sevgi Akarsu; Didem Didar Altiner; Cagnur Ulukus; Ali Tahsin Güneş

Angioma serpiginosum is a rare benign vascular disorder, characterized clinically by multiple minute, red to purple, grouped macules in serpiginous and gyrate patterns and histopathologically by ectatic dilatation of capillaries. Patients can undergo unnecessary hematological tests, because the condition can be confused with chronic purpuric dermatoses. An 18‐year‐old man with angioma serpiginosum of his left arm was evaluated by dermoscopy and treated with pulsed dye laser. Numerous small, relatively well‐demarcated, round to oval red lagoons were determined with dermoscopy, and approximately 75% of the area of his lesion disappeared after four sessions of pulsed dye laser. Our case supports the hypothesis that dermoscopy is beneficial in the diagnosis of angioma serpiginosum and that pulsed dye laser is effective in the treatment of this disorder.


Journal of Dermatology | 2012

Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris

Sevgi Akarsu; Emel Fetil; Filiz Yücel; Eylem Gül; Ali Tahsin Güneş

Clindamycin phosphate (CDP), benzoyl peroxide (BPO) and salicylic acid (SA) are known to be effective acne therapy agents depending on their anti‐inflammatory and comedolytic properties. The purpose of this study was to investigate the efficacy and tolerability of the addition of SA treatment to CDP and BPO (SA and CDP + BPO) and compare it with CDP + BPO in patients with mild to moderate facial acne vulgaris. Forty‐nine patients were enrolled in a 12 week prospective, single‐blind, randomized, comparative clinical study. Efficacy was assessed by lesion counts, global improvement, quality of life index and measurements of skin barrier functions. Local side effects were also evaluated. Both combinations were effective in reducing total lesion (TL), inflammatory lesion (IL) and non‐inflammatory lesion (NIL) counts. There were statistically significant differences between treatment groups for reductions in NIL counts beyond 2 weeks, IL counts and TL counts throughout the all study weeks, and global improvement scores evaluated by patients and investigator at the end of the study in favor of SA and CDP + BPO treatment when compared to CDP + BPO treatment. Both combinations significantly decreased stratum corneum hydration, although skin sebum values decreased with SA and CDP + BPO treatment. These combinations were also well tolerated except significantly higher frequency of mild to moderate transient dryness in patients applied SA and CDP + BPO. The addition of SA to CDP + BPO treatment demonstrated significantly better and faster results in terms of reductions in acne lesion counts and well tolerated except for higher frequency of mild to moderate transient dryness.


Journal of Dermatology | 2011

Heterogeneous disease: a child case of lichen planus pemphigoides triggered by varicella.

Turna Ilknur; Sevgi Akarsu; Soner Uzun; Erdener Özer; Emel Fetil

Lichen planus pemphigoides (LPP) is a rare and controversial disease. It is characterized clinically by tense bullae arising both on lichen planus papules and on uninvolved skin, histologically by the demonstration of subepidermal bullae and by linear deposits of immunoglobulin G and C3 along the basement membrane zone on immunofluorescence of peribullous skin. Some authors consider LPP as the combination of lichen planus and bullous pemphigoid. Others think that it most likely encompasses a heterogeneous group of subepidermal autoimmune blistering disorders occurring in association with lichen planus. We present a child case that supports the heterogeneous condition of this disease triggered by varicella.


International Journal of Dermatology | 2013

Lichen planus pigmentosus distributed along the lines of Blaschko

Sevgi Akarsu; Turna Ilknur; Erdener Özer; Emel Feti̇l

References 1 Kazandjieva J, Gergovska M, Darlenski R, et al. Recall dermatitis after systemic treatment with paclitaxel. Int J Dermatol 2010; 49: 956–959. 2 Ruocco V, Brunetti G, Puca RV, Ruocco E. The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites. J Eur Acad Dermatol Venereol 2009; 23: 1364–1373. 3 Ruocco V, Ruocco E, Brunetti G, Wolf R. Achilles’ heel in dermatology. J Eur Acad Dermatol Venereol 2010; 24: 1119–1120. 4 Mallon E, Powell S, Mortimer P, Ryan TJ. Evidence for altered cell-mediated immunity in post-mastectomy lymphoedema. Br J Dermatol 1997; 137: 928–933.


Photodermatology, Photoimmunology and Photomedicine | 2006

Effects of some emollients on the transmission of ultraviolet

Emel Fetil; Sevgi Akarsu; Turna Ilknur; Ergun Kusku; Ali Tahsin Güneş

Background/purpose: Various topical agents which can be used in combination with phototherapy may have blocking or enhancing effects. In this in vivo study, the effects of topical petrolatum, basis cream, glycerine and olive oil on the transmission of ultraviolet B (UVB) were investigated.

Collaboration


Dive into the Sevgi Akarsu's collaboration.

Top Co-Authors

Avatar

Emel Fetil

Dokuz Eylül University

View shared research outputs
Top Co-Authors

Avatar

Turna Ilknur

Dokuz Eylül University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Banu Lebe

Dokuz Eylül University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fatma Semiz

Dokuz Eylül University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge